Impact of Artificial Intelligence on Medical Devices

impact-of-artificial-intelligence-on-medical-devices

In healthcare, artificial intelligence (AI) is reshaping medical devices and diagnostics. The US FDA’s approval of 91 AI-enabled devices in 2022 underscores the transformative potential of this technology. Radiology leads the way, with three-quarters of approvals. Healthcare technology management in Dublin, California embraces these advancements, integrating AI into medical devices for enhanced diagnostics.

Cardiology follows suit, with 11% of AI-approved devices dedicated to this field. Medical equipment repair in Valencia, California plays a vital role in maintaining the functionality of high-tech cardiology devices. Siemens Healthineers, a major contributor with 29 approvals, exemplifies how medical equipment repair is crucial for cutting-edge healthcare technology.

Biomedical technology in California is experiencing a surge, particularly in neurology and hematology. Smaller companies like iRhythm Technologies, collaborating with Verily Life Sciences, introduce innovative devices such as the ZEUS System and Zio Watch. This highlights the synergy between AI and biomedical technology, advancing patient care and diagnostics.

The influence of AI extends to established medical device companies, like Medtronic, contributing to FDA-approved lists. Their products, from continuous glucose monitoring to colorectal cancer detection, showcase the diverse applications of AI in healthcare.

In the pharmaceutical realm, partnerships between AI-focused firms and industry giants are flourishing. Paige AI collaborates with Johnson & Johnson’s Janssen unit for an AI-based bladder cancer screening test. PathAI, in affiliation with Bristol-Myers Squibb, GlaxoSmithKline, and Roche, has received FDA approval for its digital pathology platform, AISight DX, which expedites diagnostics and drug development.

Looking ahead, a GlobalData report projects AI to be a significant driver of medical device innovation in 2023, with a market growth of $93 billion. The integration of AI into medical devices not only promises improved diagnostics and treatments but also spearheads a new era of innovation and patient-centric care.

For healthcare facilities seeking comprehensive biomedical services, contact Advantage Biomedical Services today!

sample-image

Touma G. Bitar
Advantage Biomedical Services, INC

This entry was posted in Artificial Intelligence Impact and tagged , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *